Experimental COVID Pill Shows Edge Over Paxlovid as Traws Hits Key Milestones
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) said it has completed enrollment in a 90-patient Phase 2 study testing its experimental oral COVID-19 treatment ratutrelvir against PAXLOVID®, reporting early …
Experimental COVID Pill Shows Edge Over Paxlovid as Traws Hits Key Milestones Read More